article thumbnail

Omega Therapeutics Entered into a Clinical Supply Agreement with Roche to Evaluate OTX-2002 for Hepatocellular Carcinoma

PharmaShots

Shots: The companies collaborated to evaluate the safety, tolerability, PK, PD & preliminary antitumor activity of OTX-2002 as monotx. The preliminary results from the monotx.

article thumbnail

$2 billion mRNA-based oncology therapy market anticipated by 2029

European Pharmaceutical Review

During the American Society of Clinical Oncology (ASCO) 2023 annual meeting, BioNTech revealed promising Phase I results for the pancreatic cancer drug BNT122 combined with the immune checkpoint inhibitor (ICI) atezolizumab. percent of the total mRNA therapy market by 2029. percent of the total mRNA therapy market by 2029.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

mRNA non-vaccine therapeutics to generate $2 billion by 2028

European Pharmaceutical Review

GlobalData stated that if development is successful for Ultragenyx’s OTX-2002 , which has potential to be the first programmable epigenetic medicine, it could generate $1.6 billion during 2028. The post mRNA non-vaccine therapeutics to generate $2 billion by 2028 appeared first on European Pharmaceutical Review.

article thumbnail

Changing Faces: biopharma hires from November 2022

pharmaphorum

Stefan Woxström is the new senior vice president for Europe and Canada at AstraZeneca, moving over from the company’s Japanese division to take over from Iskra Reic , who will now serve as EVP of vaccines and immune therapies. Diaz has been with Almirall since 2002, most recently serving as senior director of corporate strategy.

article thumbnail

Melatonin side effects and how to avoid them

The Checkup by Singlecare

This includes people with: Kidney disease Liver disease Seizure disorders Autoimmune conditions Melatonin increases immune system activity, so it may increase the risk of flare-ups in people with autoimmune disorders.

article thumbnail

Top 20 Drugs with US Patent Expiry in 2023 Based on Total Sales Value

PharmaShots

Company: Jazz Pharmaceuticals Generic Name: Sodium Oxybate First Approval Date: Jul 17, 2002 Patent Expiration: Jun 2023 2022 Sales: $1B Indication: Narcolepsy Xyrem is an oral solution for treating two common symptoms of narcolepsy, i.e., excessive daytime sleepiness (EDS) and cataplexy.

FDA 49
article thumbnail

Using alkali-metal cation recognition of ?-cyclodextrin to detect lithium ions by MALDI-TOF

European Pharmaceutical Review

Johan’s PhD studies at the University of Gothenburg were focused on food and allergy, and the effect of fatty acids on immune cells. Enzymatic production of cyclodextrins, Applied Microbiology and Biotechnology , 2002, 59, 609-617. The next year he worked as a service technician of laboratory instruments. 2021, 32, 289–300.